Literature DB >> 34035723

Best Use of the Transjugular Intrahepatic Portosystemic Shunt Procedure for the Management of Portal Hypertension.

Lisa B VanWagner1.   

Abstract

Entities:  

Year:  2020        PMID： 34035723      PMCID： PMC8132687     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

Authors:  Francesco Salerno; Calogero Cammà; Marco Enea; Martin Rössle; Florence Wong
Journal:  Gastroenterology       Date:  2007-06-20       Impact factor: 22.682

2.  The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

3.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.

Authors:  Guadalupe Garcia-Tsao; Juan G Abraldes; Annalisa Berzigotti; Jaime Bosch
Journal:  Hepatology       Date:  2016-12-01       Impact factor: 17.425

Review 4.  Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.

Authors:  Matthew L Hung; Edward Wolfgang Lee
Journal:  Clin Liver Dis       Date:  2019-08-31       Impact factor: 6.126

5.  A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.

Authors:  Agustín Albillos; Rafael Bañares; Mónica González; María-Vega Catalina; Luis-Miguel Molinero
Journal:  J Hepatol       Date:  2005-07-05       Impact factor: 25.083

6.  Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.

Authors:  Christophe Bureau; Dominique Thabut; Frédéric Oberti; Sébastien Dharancy; Nicolas Carbonell; Antoine Bouvier; Philippe Mathurin; Philippe Otal; Pauline Cabarrou; Jean Marie Péron; Jean Pierre Vinel
Journal:  Gastroenterology       Date:  2016-09-20       Impact factor: 22.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.